Zobrazeno 1 - 10
of 37
pro vyhledávání: '"civas"'
Autor:
Vrignaud Sandy
Publikováno v:
Pharmaceutical Technology in Hospital Pharmacy, Vol 2, Iss 3, Pp 137-142 (2017)
The aim of the European Council’s Resolution CM/res(2016)2 on good reconstitution practices in health care establishments for medicinal products for parenteral use is to guide the health care establishment’s decision as to where reconstitution sh
Externí odkaz:
https://doaj.org/article/96697bd0f7a341e1a5c18d230d3dacac
Publikováno v:
Pharmaceutical Technology in Hospital Pharmacy, Vol 2, Iss 2, Pp 79-84 (2017)
In hospitals, a major part of the drugs is administered via the intravenous route. When one wants to evaluate or know the stability of a drug in solution, it is necessary to know several physico-chemical parameters. Several reference works are availa
Externí odkaz:
https://doaj.org/article/7d5b911b1b774ac5acf95e953caaf9f2
Autor:
Benoît Bihin, Marie-Lise Colsoul, Laura Soumoy, M Closset, Jacques Jamart, Jean-Daniel Hecq, Laurence Galanti, Nicolas Goderniaux, Sabrina Onorati, Pascal Odou
Publikováno v:
Journal of chemotherapy, Vol. 33, no. 7, p. 486-491 (2021)
Management of chemotherapies is a strategic issue for european healthcare. Dose-banding enables to reduce waiting time of patients in day care units and drug wastage. The aim of this study was to assess the stability of 5-Fluorouracile (5-FU) at stan
Publikováno v:
CHIMIA, Vol 66, Iss 5 (2012)
Injectable drugs are high-risk products and their reconstitution in hospital wards is a potential source of errors. Thus, in order to secure the reconstitution process and thereby improve safety, the pharmacy department of Lausanne University Hospita
Externí odkaz:
https://doaj.org/article/598059555d2842a3bc4f7bfd6fb954ab
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sandy Vrignaud
Publikováno v:
Pharmaceutical Technology in Hospital Pharmacy, Vol 2, Iss 3, Pp 137-142 (2017)
The aim of the European Council’s Resolution CM/res(2016)2 on good reconstitution practices in health care establishments for medicinal products for parenteral use is to guide the health care establishment’s decision as to where reconstitution sh
Publikováno v:
Hecq, J-D, Bihin, B, Jamart, J & Galanti, L 2017, ' Criteria for Judging the Quality of a Publication on Physicochemical Stability of Ready to Use Injectable Drugs ', Pharmaceutical Technology in Hospital Pharmacy, vol. 2, no. 2 . https://doi.org/10.1515/pthp-2017-0012
Pharmaceutical Technology in Hospital Pharmacy, Vol 2, Iss 2, Pp 79-84 (2017)
Pharmaceutical Technology in Hospital Pharmacy, Vol 2, Iss 2, Pp 79-84 (2017)
In hospitals, a major part of the drugs is administered via the intravenous route. When one wants to evaluate or know the stability of a drug in solution, it is necessary to know several physico-chemical parameters. Several reference works are availa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24e0014542b74aca9aee90c9abd3cebc
https://pure.unamur.be/ws/files/53091374/_5B2365242X_20_20Pharmaceutical_20Technology_20in_20Hospital_20Pharmacy_5D_20Criteria_20for_20Judging_20the_20Quality_20of_20a_20Publication_20on_20Physicochemical_20Stability_20of_20Ready_20to_20Use_20Injectable_20Drugs.pdf
https://pure.unamur.be/ws/files/53091374/_5B2365242X_20_20Pharmaceutical_20Technology_20in_20Hospital_20Pharmacy_5D_20Criteria_20for_20Judging_20the_20Quality_20of_20a_20Publication_20on_20Physicochemical_20Stability_20of_20Ready_20to_20Use_20Injectable_20Drugs.pdf
Autor:
Feutry, Frédéric
La centralisation de la préparation des médicaments injectables à la pharmacie permet d’assurer un haut niveau de qualité mais nécessite une stabilité du médicament dans le conditionnement choisi et une capacité de production suffisantes. A
Externí odkaz:
http://www.theses.fr/2016LIL2S021
Publikováno v:
International Journal of Pharmaceutics
International Journal of Pharmaceutics, Elsevier, 2015, 492, pp.137-40. ⟨10.1016/j.ijpharm.2015.07.019⟩
International Journal of Pharmaceutics, Elsevier, 2015, 492, pp.137-40. ⟨10.1016/j.ijpharm.2015.07.019⟩
International audience; Micafungin is a costly treatment and packaging of 50mg or 100mg bottles only are available, while doses lower than 5mg and 20mg are often necessary in neonates and paediatrics patients, respectively. The stability of micafungi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b6c1e48b4dab54a0cc2cb7f62941769
https://hal.archives-ouvertes.fr/hal-01392457
https://hal.archives-ouvertes.fr/hal-01392457
Publikováno v:
CHIMIA, Vol 66, Iss 5 (2012)
Injectable drugs are high-risk products and their reconstitution in hospital wards is a potential source of errors. Thus, in order to secure the reconstitution process and thereby improve safety, the pharmacy department of Lausanne University Hospita